ArticleIntestinal research2019

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study.

Toshifumi Hibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.